Articles from AptarGroup, Inc.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2025 by Newsweek for the sixth consecutive year. Aptar is ranked number 71 out of 600 U.S. companies.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced their participation at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2024 by Forbes for the fourth consecutive year (formerly World’s Top Female Friendly Companies). Aptar is ranked 41 out of the 400 companies included on the list by Forbes and their partner Statista. For this ranking companies were evaluated in three categories including employer brand, public opinion and leadership.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong third quarter results due to solid operational performance and margin improvement across the company. Results were driven by growth in proprietary drug delivery systems, as well as increased demand for closure technologies. Reported sales and core sales increased by 2%, as currency and acquisition effects did not impact the quarter. Aptar reported net income of $100 million for the quarter, a 19% increase from the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, announced that it was awarded a contract from the U.S. Federal Government to advance development of its ActivShield™ technology. This innovative solution sterilizes medical devices and instruments without the need for a power source, making it a versatile solution for numerous environments, including rural areas, military settings and healthcare facilities with limited or no current sterilization capability.

The Board of Directors of AptarGroup, Inc. (NYSEATR) authorized the repurchase of up to $500 million of the Company’s common stock. This new authorization replaces all previous authorizations. Aptar may repurchase shares through the open market, privately negotiated transactions or other programs, subject to market conditions. The Board also declared a quarterly cash dividend of $0.45 per share. The payment date is November 14, 2024, to stockholders of record as of October 24, 2024.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, announced that its N-Sorb nitrosamine mitigation solution has been accepted into the U.S. Food & Drug Administration’s (FDA) Emerging Technology Program (ETP), which helps promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Unidose Liquid System (Unidose) is the delivery system approved with neffy® (epinephrine nasal spray), the first and only needle-free treatment approved by the U.S. FDA for the emergency treatment of patients with allergic reactions (Type I), including anaphylaxis. This marks the first regulatory approval worldwide for nasally-delivered epinephrine.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Daniel Ackerman has been named Chief Accounting Officer, effective August 1, 2024.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Bob Kuhn, Executive Vice President and Chief Financial Officer (CFO) since 2008, has decided to retire at the end of this year.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported solid second quarter results driven by continued growth of the company’s proprietary drug delivery systems and margin improvement. Reported sales increased by 2% and core sales, excluding currency and acquisition effects, increased by 3%. Aptar reported net income of $90 million for the quarter, a 9% increase from the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share, an almost 10% increase from the previous dividend amount, bringing the new annualized dividend to $1.80 per share. The payment date is August 15, 2024, to stockholders of record as of July 25, 2024.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of the World’s Most Sustainable Companies 2024 by TIME. Aptar is ranked 194 out of top 500 global companies evaluated by TIME and its partner Statista.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and protection technologies was named one of America’s Climate Leaders 2024 by USA Today.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today released its 2023 Corporate Sustainability / Environment, Social and Governance (ESG) Report entitled Progress Takes Shape. Aptar’s report highlights key milestones of its global sustainability strategy across the company’s global operations focused on three key pillars:

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies has achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis for the fourth consecutive year. The Platinum rating places Aptar among the top 1% of the more than 125,000 companies rated by EcoVadis across all industries.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong first quarter results driven by continued growth of the company’s proprietary drug delivery systems, increased injectables sales and an improving picture for consumer dispensing technologies in North America. Reported sales increased by 6% and core sales, excluding currency and acquisition effects, increased by 5%. Aptar reported net income of $83 million for the quarter, a 52% increase over the prior year. Reported earnings per share increased 50% to $1.23 and adjusted earnings per share increased 31% to $1.26.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is May 16, 2024, to stockholders of record as of April 25, 2024.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, was named to the CDP Supplier Engagement Leaderboard, for the fourth consecutive year. Aptar is among over 450 companies that have made it onto CDP’s most recent Supplier Engagement Leaderboard based on its 2023 CDP disclosure and was cited for its contributions to emissions reductions throughout the value chain.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has been named one of Barron’s 100 Most Sustainable U.S. Companies for the sixth consecutive year and is ranked number 29 out of 100 companies for 2024.

Aptar Digital Health, part of AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has entered into an enterprise agreement with Biogen Inc. (Nasdaq: BIIB) to operate and develop digital health solutions for neurological and rare diseases. As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong fourth quarter operational results driven by double-digit growth of the company’s proprietary drug delivery systems and strong growth for fragrance dispensing technologies. Reported sales increased by 5% and core sales, excluding currency and acquisition effects, increased by 2%. Aptar reported net income of $62 million for the quarter, a 6% increase over the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named one of America’s Most Responsible Companies 2024 by Newsweek for the fifth consecutive year. Aptar is ranked number 29 out of 600 U.S. companies and is ranked first in its industry category.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is February 22, 2024, to stockholders of record as of February 1, 2024.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their participation at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, is announcing a contract with the U.S. Food and Drug Administration (FDA) to study the challenges with developing low Global Warming Potential (low-GWP) propellant metered dose inhalers (MDIs).

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named a World’s Top Companies for Women 2023 by Forbes for the third consecutive year (formerly World’s Top Female Friendly Companies). Aptar is among the top 5% of companies, ranked 13 out of the 400 companies included on the list by Forbes and their partner Statista. For this ranking companies were evaluated in three categories including employer brand, public opinion and leadership.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong operational performance driven by continued growth of the company’s proprietary drug delivery systems. Strong sales from prestige and mass fragrance dispensing devices also contributed positively to the results. Reported sales increased by 7% and core sales, excluding currency and acquisition effects, increased by 2%. Aptar reported net income of $84 million for the quarter, a 55% increase over the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that it has been named to 3BL Media’s 100 Best Corporate Citizens list for the third consecutive year in a row for environmental, social and governance (ESG) transparency and performance. 3BL and its partner, Institutional Shareholder Services (ISS) ESG, evaluates the 1,000 largest, publicly traded U.S. companies for this ranking. Aptar is ranked 34 out of the 100 companies evaluated.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.41 per share. The payment date is November 16, 2023, to stockholders of record as of October 26, 2023.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that Sarah Glickman, an accomplished leader with more than 30 years of global financial and operational experience, has joined its Board of Directors.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, will host an Investor Day on Friday, September 8, 2023. The event will begin at 10:00 a.m. EDT. Presentations by members of executive management followed by a moderated Q&A session are expected to conclude at approximately 12:15 p.m. EDT.

AptarGroup, Inc. (NYSEATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today reported strong operational performance driven by continued growth of the company’s proprietary drug delivery systems and significant sequential improvement in injectables sales as Enterprise Resource Planning (ERP) system implementation effects moderated. Strong sales from prestige and mass fragrance also contributed positively to the results. Reported sales increased by 6% and core sales, excluding currency and acquisition effects, increased by 4%. Aptar reported net income of $83 million for the quarter, a 31% increase over the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.41 per share, an almost 8% increase from the previous dividend amount, bringing the new annualized dividend to $1.64 per share. The payment date is August 17, 2023, to stockholders of record as of July 27, 2023.

AptarGroup, Inc. (NYSEATR), today announced with great sadness that Ervin “Erv” J. LeCoque, the first Chief Executive Officer and Chairman of the Board when Aptar became a publicly traded company, has passed away.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today released its 2022 Corporate Sustainability / ESG Report entitled Purpose Takes Shape. Aptar’s 2022 Corporate Sustainability / ESG Report highlights key milestones and global sustainability strategy progress across the Company’s global operations.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, was named one of America’s Climate Leaders 2023 by USA Today on its inaugural list of 400 US companies. Aptar is ranked first in its industry sector and 24th among the companies who achieved the greatest reduction in their core emissions intensity between 2019 and 2021 – that is, Scope 1 and 2 greenhouse gas emissions in relation to revenue.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that Candace Matthews has been elected independent chairperson of the company’s Board of Directors, effective immediately following the company’s 2023 annual meeting of stockholders on May 3, 2023. Candace will succeed George Fotiades, who will remain on the Board of Directors.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported strong operational performance driven by Aptar’s Pharma and Beauty segments. Reported sales increased by 2% and core sales, excluding currency and acquisition effects, increased 4%. Aptar reported net income of $55 million for the quarter, a 12% decrease over the prior year, primarily due to restructuring charges.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is May 25, 2023, to stockholders of record as of May 4, 2023.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segment realignment of two of its business reporting segments.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, was named to the CDP Supplier Engagement Leaderboard for the third consecutive year. Aptar is among the top 8% assessed for supplier engagement on climate change, based on its 2022 CDP disclosure, and was cited for its contributions to emissions reductions throughout the value chain.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that it has updated its Scope 1 and 2 science-based targets, setting an emissions reduction goal consistent with requirements to limit global temperature rise to 1.5° Celsius by year 2030.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has been named one of Barron’s 100 Most Sustainable Companies for the fifth consecutive year and is ranked number 55 out of 100 companies for 2023.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Julie Xing has joined its Board of Directors.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $59 million for the quarter ended December 31, 2022, a 2% increase over the prior year. Reported sales decreased 2% and core sales, excluding currency and acquisition effects, increased by 4% over the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has again achieved the Platinum level rating in recognition of its sustainability efforts from EcoVadis. The Platinum rating places Aptar among the top 1% of the more than 90,000 companies rated by EcoVadis across all industries.

Aptar Pharma, part of AptarGroup, Inc. (NYSEATR), a global leader in drug delivery systems, services and active material science solutions, today announces the launch of APF Futurity, its first metal-free, multidose nasal spray pump developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is February 23, 2023, to stockholders of record as of February 2, 2023.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced their participation at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has been named one of America’s Most Responsible Companies 2023 by Newsweek and is ranked #15 out of 500 U.S. companies. Aptar is also ranked first in its industry category.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced that it will realign two of its business reporting segments effective January 1, 2023. Aptar’s two renamed reporting segments will be Aptar Closures and Aptar Beauty. The new segment structure is designed to streamline operations, improve efficiencies and enable a stronger customer focus across all closure applications.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today announced it has again been named one of the World’s Top Female-Friendly Companies by Forbes. Aptar is ranked 70 out of the 400 companies included for 2022. For this ranking, Forbes partnered with Statista to identify global companies leading the way in supporting women in the workplace and world at large.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $54 million for the quarter ended September 30, 2022, a 15% increase over the prior year. Reported sales grew 1% and core sales, excluding currency and acquisition effects, increased by 9% over the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is November 16, 2022, to stockholders of record as of October 26, 2022.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that Matt Trerotola has joined its Board of Directors.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported net income of $64 million for the quarter ended June 30, 2022, a 15% increase over the prior year. Reported sales grew 4% and core sales increased by 10% over the prior year.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is August 17, 2022, to stockholders of record as of July 27, 2022.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today released its 2021 Corporate Sustainability / ESG Report entitled Better Takes Shape. Aptar’s 2021 Corporate Sustainability / ESG Report highlights activities across the Company’s global operations and summarizes milestones measured and achieved in the key areas of its global sustainability strategy.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, announced today that it has been named to 3BL Media’s 100 Best Corporate Citizens ranking for the second year in a row for environmental, social and governance (ESG) transparency and performance. 3BL Media, in partnership with Institutional Shareholder Services (ISS) ESG, evaluated the 1,000 largest public U.S. companies regarding ESG and Aptar is among the top 100 companies.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported first quarter results for 2022.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today declared a quarterly cash dividend of $0.38 per share. The payment date is May 18, 2022, to stockholders of record as of April 27, 2022.

AptarGroup, Inc. (NYSEATR) today announced with deep sadness that Jesse Wu, a director of the Company, has passed away. Mr. Wu served on the Board of Directors since 2018 and was a member of the Management Development & Compensation Committee.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, has again been named one of Barron’s 100 Most Sustainable Companies. Aptar is ranked number 70 for 2022 and this marks the fourth consecutive year Aptar has been included on Barron’s esteemed list.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported fourth quarter and annual results for 2021.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, has received the Platinum level rating in recognition of its sustainability efforts from EcoVadis. The Platinum rating places Aptar among the top 1% of the nearly 85,000 companies rated by EcoVadis across all industries.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is February 23, 2022, to stockholders of record as of February 3, 2022.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material solutions, has been named one of America’s Most Responsible Companies 2022 by Newsweek and is ranked #10 out of 500 U.S. companies. Aptar is also ranked first in its industry category.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material solutions is named one of the Most Responsible Companies in France for 2022 by Le Point. Aptar ranks in the top 100 companies for its efforts in the areas of Environment, Social and Governance (ESG).

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material solutions, announced today that it has been ranked #1 on Forbes’ Green Growth 50 2021 inaugural list. As part of the Green Growth 50, Forbes is highlighting large American corporations that have managed to cut their greenhouse gas emissions, while simultaneously growing earnings.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material solutions, is named one of the World’s Top Female-Friendly Companies 2021 by Forbes. Aptar is ranked in the top ten and is number eight out of the 300 companies included for 2021. Forbes teamed with Statista to identify companies leading the way to support women inside and outside of their workforces, including making meaningful changes to address the burdens women have faced during the COVID-19 pandemic.

AptarGroup, Inc. (NYSEATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported third quarter results for 2021.